Advisory Board Members

Our advisory board is composed of premiere professionals representing critical areas across the healthcare continuum.

Frank McGillin

Digital Health, Med Tech and Consumer

Frank McGillin is a seasoned CEO and growth leader with more than 25 years of experience building and scaling businesses at the intersection of healthcare, consumer innovation, and technology. He has led organizations through digital transformation, global commercialization, and strategic partnerships, consistently delivering growth across complex markets. Frank’s leadership spans Fortune 500 companies and startups, including Philips, Johnson & Johnson, NeuroMetrix, and The Clinic by Cleveland Clinic a joint venture created to accelerate digital care innovation.

As a board director and strategic advisor, Frank brings a unique blend of go-to-market experience, operational acumen, and market insight. He partners with boards, investors, and leadership teams to guide commercialization strategy, organizational transformation, and AI enabled care.

Board & Advisory Experience:

  • CancerCare.org – Board Member; digital health & strategy advisor
  • Clinic by Cleveland Clinic – Collaborated with the board on strategy to address existential regulatory changes. Established joint venture governance and secured ongoing funding
  • NeuroMetrix, Inc. – Supported board on strategy, M&A, and investor relations
  • Advisor – Member of Cleveland Clinic Innovation’s Executive Advisory Council. Strategic consultant to several early-stage health tech ventures

Selected Leadership Experience:

  • Chief Executive Officer, The Clinic by Cleveland Clinic & Amwell – Built and scaled a digital health joint venture, securing $30M in funding and establishing partnerships with Optum, Elevance, and Highmark
  • Chief Commercial Officer, NeuroMetrix – Transformed the business into a digital health innovator and negotiated a $26M global licensing deal with GSK • Vice President & General Manager, Philips – Scaled Sonicare into a $1B+ global brand and restructured marketing for $10B medical division

Ask Us